Synthesis, Spectroscopy, and Applications of Small Nitrile Oxides
- 期刊名称Current Organic Chemistry
- 作者Pasinszki, Tibor; P. C. Westwood, Nicholas
- 卷第15卷
- 期第11期
- 印刷ISSN1385-2728
- 文件大小270.72KB
- 发表时间2011-06-01
- DOI10.2174/138527211795656615
- 页码1720-1733
Nuclear export of proteins and drug resistance in cancerJoel G. Turner; Jana Dawson; Daniel M. Sullivan · 2012
Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agentsTurner, Joel G.; Dawson, Jana; Cubitt, Christopher L.; Baz, Rachid; Sullivan, Daniel M. · Seminars in Cancer Biology · 2014
Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitorsTurner, Joel G.; Dawson, Jana L.; Grant, Steven; Shain, Kenneth H.; Dalton, William S.; Dai, Yun; Meads, Mark; Baz, Rachid; Kauffman, Michael; Shacham, Sharon; Sullivan, Daniel M. · Journal of Hematology & Oncology · 2016
CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex VivoTurner, Joel G.; Dawson, Jana; Emmons, Michael F.; Cubitt, Christopher L.; Kauffman, Michael; Shacham, Sharon; Hazlehurst, Lori A.; Sullivan, Daniel M. · Journal of Cancer · 2013
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid LeukemiaSweet, Kendra; Komrokji, Rami; Padron, Eric; Cubitt, Christopher L.; Turner, Joel G.; Zhou, Junmin; List, Alan F.; Sallman, David A.; Dawson, Jana L.; Sullivan, Daniel M.; Chavez, Julio; Shah, Bijal D.; Lancet, Jeffrey E. · Clinical Cancer Research · 2020
Broadened Clinical Utility of Gene Gun-Mediated, Granulocyte-Macrophage Colony-Stimulating Factor cDNA-Based Tumor Cell Vaccines as Demonstrated with a Mouse Myeloma ModelTurner, Joel G.; Tan, Jun; Crucian, Brian E.; Sullivan, Daniel M.; Ballester, Oscar F.; Dalton, William S.; Yang, Ning-Sun; Burkholder, Joseph K.; Yu, Hua · Human Gene Therapy · 1998
XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myelomaTurner, Joel G.; Kashyap, Trinayan; Dawson, Jana L.; Gomez, Juan; Bauer, Alexis A.; Grant, Steven; Dai, Yun; Shain, Kenneth H.; Meads, Mark; Landesman, Yosef; Sullivan, Daniel M. · Oncotarget · 2016
Subject Index To Volume 6Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal Chemistry - Central Nervous System Agents) · 2007
Subject Index to Volume 5Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal Chemistry - Central Nervous System Agents) · 2006
Subject Index to Volume 5Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) · 2006
Subject Index To Volume 6Immunology Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents) · 2007
Author Index to Volume 5Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents) · 2006
Subject Index to Volume 5Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents) · 2006
Author Index To Volume 6Immunology Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents) · 2007
Author Index Volume 3Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents) · 2006